Design and synthesis of carbohydrate derivatives for antagonistic activity at muscarinic receptor

Letters in Drug Design and Discovery

Volumn 5, Issue 4, 2008, Pages 236-242

  Da Rocha, David R ^a   Ferreira, Vitor F ^a   Garcez do Carmo, Lúcia ^b   Santos, Wilson C ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Atropine; Carbohydrates; Cholinergic neurotransmission; Muscarinic receptor

Indexed keywords

3 PHENYL 5 DEOXY 5 (DIETHYLAMINO) 1,2 O ISOPROPYLIDENE ALPHA DEXTRO RIBOFURANOSE; 3 PHENYL 5 DEOXY 5 (DIETHYLAMINO)ALPHA DEXTRO RIBOFURANOSE; ATROPINE; CARBOHYDRATE DERIVATIVE; GLUCOSE; MUSCARINE; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; POTASSIUM CHLORIDE; PROCYCLIDINE;

ANIMAL TISSUE; ARTICLE; CHOLINERGIC TRANSMISSION; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; JEJUNUM; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 45249083895     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018008784619870     Document Type: Article

References (45)

1. Brunton, L.L.; Lazo, J.S.; Parker, K.L. In Goodman & Gilman's The Pharmacological Basis of Therapeutics, Westfall, T. C.; Westfall, D. P., eds.; McGraw-Hill: New York, 2006.
2. Hook, V.Y.H. Cel. Mol. Neurobiol., 2006, 26, 449.
3. Fine, A.; Hoyle, C.; Maclean, C.J.; Levatte, T.L.; Baker, H.F.; Ridley, R.M. Neuroscience, 1997, 81, 331.
4. Newman, M.B.; Nazian, S.J.; Sanberg, P.R.; Diamond, D.M.; Shytle, R.D. Prog. Neuropsycopharmacol. Biol. Psychiatr., 2001, 25, 609.
5. Tzavara, E.T.; Bymaster, F.P.; Davis, R.J.; Wade, M.R.; Perry, K.W.; Wess, J.; McKinzie, D.L.; Felder, C.; Nomikos, G.G. FASEB J., 2004, 18, 1410.
6. Alberghina, L.; Colangelo, A.M. BMC Neurosci., 2006, 7, S2.
7. Schenkman, M.; Zhu, C.W.; Cutson, T.M.; Whetten-Goldstein, K. Parkinsonism Relat. D., 2001, 8, 41.
8. Le, W.D.; Jankovic, J. Drugs Aging, 2001, 18, 389.
9. Olanow, C.W. Annu. Rev Med., 2004, 55, 41.
10. Golubnitschaja, O. Amino Acids, 2007, 32, 359.
11. Viegas Junior, C.; Bolzani, V.S.; Furlan, M.; Fraga, C.A.M.; Barreiro, E.J. Quim. Nova, 2004, 27, 655.
12. Seltzer, B. J. Int. Med. Res., 2006, 34, 339.
13. Hermanowicz, N. Semin. Neurol., 2007, 27, 97.
14. Brocks, D. R. J. Pharm. Pharm. Sci., 1999, 2, 39.
15. Lees, A. Drug Aging, 2005, 22, 731.
16. Caulfield, M. P.; Birdsall, N. J. Pharmacol. Rev., 1998, 50, 279.
17. Bonner, T.I.; Buckley, N.J.; Young, A.C.; Brann, M. R. Science, 1987, 237, 527.
18. Kubo, T.; Fukuda, K.; Mikami, A.; Maeda, A.; Takashi, H.; Mishina, M.; Haga, T.; Haga, K.; Ichiyama, A.; Kangawa, K. Nature, 1986, 323, 411.
19. Kubo, T.; Maeda, A.; Sugimoto, K.; Akiba, I.; Mikami, A.; Takahashi, H.; Haga, T.; Haga, K.; Ichiyama, A.; Kangawa, K. FEBS Lett., 1986, 209, 367.
20. Olgart C.; Iversen, H.H. Br. J. Pharmacol., 1999, 127, 309.
21. Grangeiro, M.S.; Calheiros-Lima, A.P.; Martins, M.F.; Arruda, L.F.; Garcez-do-Carmo, L.; Santos, W.C. J. Ethnopharmacol., 2006, 108, 26.
22. Garcez-do-Carmo, L.; Abillos, A.; Artalejo, A.; Fuente, M. T.; Lopez, M.; Gandia, L.; Michelena, P.; Garcia, A. G. Br. J. Pharmacol., 1993, 110, 1149.
23. Santos, W.C.; Hernández-Guijo, J.M.; Ruiz-Nuño, A.; Olivares, R.; Jurkiewicz A.; Gandía, L.; García, A.G. Eur. J. Pharmacol., 2001, 417, 99.
24. Garcez-do-Carmo, L.; Santos, W.C. Life Sci., 2006, 79, 854.
25. Chittenden, G.J.F.; Regeling, H. Rec. Trav. Chim. Pays-Bas, 1989, 108, 330.
26. Mancuso, A.J., Swern, D. Synthesis, 1981, 165.
27. Bolden, C.; Cusack, B.; Richelson, E. J. Pharmacol. Exp. Ther., 1992, 260, 576.
28. Bolton, T.B; Lim, S.P.; Salmon, D. M.; Beech, D. J. J. Cardiovasc. Pharmacol., 1988, 12, S96.
29. Zholos, A.V.; Bolton, T.B. Br. J. Pharmacol., 1997, 122, 885.
30. Pacaud P.; Bolton T.B. J. Physiol., 1991, 441, 477.
31. Santos, W.C.; Smaili, S.S.; Jurkiewicz, A.; Piçarro, I.; Garcez-do-Carmo, L. J. Pharm. Pharmacol., 2003, 55, 373.
32. Kohlhardt, M.; Fleckenstein, A. Naunyn Schimiedebergs Arch. Pharmacol., 1977, 298, 267.
33. Furchgott, R.F. In: Catecholamines; Blaschko, H.; Muscholl, E., Eds.; Springer Verlag: Berlin, 1972, pp. 283-335.
34. Mancuso, A.J.; Huang, S.; Swern, D. J. Org. Chem., 1978, 43, 2480.
35. Yoshikawa, M.; Okaichi Y.; Cha, B.C.; Kitagawa, I. Tetrahedron, 1990, 46, 7459.
36. Fischer, J.C.; Horton, D. Carbohyd. Res., 1977, 59, 477.
37. Kumar, G.D.K.; Baskaran, S. J. Org. Chem., 2005, 70, 4520.
38. Yadav, J.S.; Raghavendra, S.; Satyanarayana, M.; Balanarsaiah, E.; Synlett, 2005, 2461.
39. Lichtenthaler, F.W.; Dinges, J.; Fukuda, Y. Angew. Chem. Int. Ed. Engl., 1991, 30, 1339.
40. Kim, S.; Oh, C.H.; Ko, J.S.; Ahn, K.H.; Kim, Y.J. J. Org. Chem., 1985, 50, 1927.
41. Winans, K.A.; Bertozzi, C.R. Chem. Biol., 2002, 9, 113.
42. Vane, J.R. Br. J. Pharmacol., 1957, 12, 344.
43. Sato, Y.; Akaoa, T.; Heb, J.; Nojima, H.; Kuraishi, Y.; Morota, T.; Asano, T.; Tani, T. J. Ethnopharmacol., 2006, 105, 409.
44. Dale, H.H. J. Pharmacol. Exp. Ther., 1914, 6, 147.
45. Van Rossum, J.M. Arch. Int. Pharmacodyn., 1963, 143, 299.